These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38989419)

  • 1. Clinical impact and potential utility of non-enhanced computed tomography performed immediately after transarterial chemoembolization for hepatocellular carcinoma.
    Kim MY; Heo S; Choi S; Suh CH; Lee ES; Park HJ; Kim KW
    J Gastrointest Oncol; 2024 Jun; 15(3):1141-1152. PubMed ID: 38989419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma.
    Niu XK; He XF
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis.
    Bargellini I; Lorenzoni V; Lorenzoni G; Scalise P; Andreozzi G; Bozzi E; Giorgi L; Cervelli R; Scandiffio R; Perrone O; Meccia DV; Boccuzzi A; Daviddi F; Cicorelli A; Lunardi A; Crocetti L; Turchetti G; Cioni R
    Eur Radiol; 2021 Oct; 31(10):7512-7522. PubMed ID: 33871708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
    Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 6. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization.
    Liu FY; Li X; Yuan HJ; Guan Y; Wang MQ
    Chin Med J (Engl); 2018 Oct; 131(20):2410-2416. PubMed ID: 30334525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
    Chen CS; Li FK; Guo CY; Xiao JC; Hu HT; Cheng HT; Zheng L; Zong DW; Ma JL; Jiang L; Li HL
    Oncotarget; 2016 Feb; 7(6):7241-52. PubMed ID: 26769845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
    Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma.
    Jun CH; Ki HS; Lee HK; Park KJ; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    World J Gastroenterol; 2013 Jan; 19(2):284-9. PubMed ID: 23345952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging biomarkers on Angio-CT for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma.
    Wang H; Han Y; Chen G; Jin L
    Quant Imaging Med Surg; 2023 Jul; 13(7):4077-4088. PubMed ID: 37456312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up after conventional transarterial chemoembolization (c-TACE) with mitomycin for hepatocellular carcinoma (HCC).
    Yamada R; Bassaco B; Bracewell S; Gillen K; Kocher M; Collins H; Anderson MB; Guimaraes M
    J Gastrointest Oncol; 2019 Apr; 10(2):348-353. PubMed ID: 31032104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
    Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
    Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.
    Zheng L; Guo CY; Chen CS; Xiao JC; Hu HT; Cheng HT; Zong DW; Jiang L; Li HL
    Oncotarget; 2017 Nov; 8(57):97613-97622. PubMed ID: 29228637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20-40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm.
    Cho SM; Chu HH; Kim JW; Kim JH; Gwon DI
    Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33919658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma.
    Chai NX; Chapiro J; Petukhova A; Gross M; Kucukkaya A; Raju R; Zeevi T; Elbanan M; Lin M; Perez-Lozada JC; Schlachter T; Strazzabosco M; Pollak JS; Madoff DC
    Clin Imaging; 2021 Aug; 76():123-129. PubMed ID: 33592550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal Vein Damage after DEB-TACE and Lipiodol-TACE: Based on Evaluation by Computed Tomography during Arterial Portography.
    Tamura M; Nakatsuka S; Torikai H; Misu M; Tsukada J; Tamura K; Ito N; Inoue M; Yashiro H; Jinzaki M
    Interv Radiol (Higashimatsuyama); 2021 Nov; 6(3):93-101. PubMed ID: 35912281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience.
    Favelier S; Boulin M; Hamza S; Cercueil JP; Cherblanc V; Lepage C; Hillon P; Chauffert B; Krausé D; Guiu B
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1039-46. PubMed ID: 23224215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balloon-occluded transarterial chemoembolization versus conventional transarterial chemoembolization for the treatment of single hepatocellular carcinoma: a propensity score matching analysis.
    Chu HH; Gwon DI; Kim GH; Kim JH; Ko GY; Shin JH; Ko HK; Yoon HK
    Eur Radiol; 2023 Apr; 33(4):2655-2664. PubMed ID: 36472699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.